If your Regulatory Agency would like to share your perspectives on a topic related to Open Target Controlled Infusions (TCI), please contact us.
by admin
Target-controlled infusion of IV anesthetic drugs is approved worldwide with the exception of the United States. We bring to your attention a special article published in January 2016 in Anesthesia and Analgesia, which reviews regulatory pathways that could lead to target-controlled infusion (TCI) clearance or approval in the United States.[1]
The Open TCI Initiative was developed initially by Dr Charles Minto (Sydney, Australia) & Professor Thomas Schnider (St Gallen, Switzerland) based on many discussions over the past years. This opentci.org website was born on 6 January 2008.
The three main goals of the Open TCI Initiative were further developed in discussion with our mentor, Professor Steven L. Shafer, on 17 January 2008 and others at the first meeting in Cape Town on 3 March 2008.